Artal Group S.A. Centessa Pharmaceuticals PLC Transaction History

Artal Group S.A.

  • $214 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$8.04 - $11.87 $5.63 Million - $8.31 Million
700,000 Added 49.56%
2,112,500 $19.1 Million
Q1 2024

May 13, 2024
BUY
$6.73 - $12.2 $2.69 Million - $4.88 Million
400,000 Added 39.51%
1,412,500 $16 Million
Q4 2023

Feb 09, 2024
BUY
$5.52 - $8.03 $5.59 Million - $8.13 Million
1,012,500 New
1,012,500 $8.06 Million

Others Institutions Holding CNTA

# of Institutions
108
Shares Held
118M
Call Options Held
5.9K
Put Options Held
53K
View Full List

About Centessa Pharmaceuticals plc

CNTA Quotes by TradingView
  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.62B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email